Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Aeon Global Health in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.09.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Aeon Global Health. This rating has held steady since February 2020, when it changed from a Hold consensus rating.
AEON Global Health Corp. engages in the development and provision of clinical services. It operates through the following segments: AEON and AHC. The AEON segment offers laboratory testing services, which includes the testing of an individual's blood, urine or saliva for the presence of drugs or chemicals and the patient's DNA profile. The AHC segment offers web-based software, which provides secure web-based revenue cycle management applications and telehealth products and services that enable health care organizations to increase revenues, improve productivity, reduce costs, coordinate care for patients and enhance related administrative and clinical workflows and compliance with regulatory requirements. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.